Citi lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $108 and keeps a Buy rating on the shares. The company reported a “subdued” Q2 but its outlook for 2025 is conservative, the analyst tells investors in a research note. The firm slightly reduced estimates post the earnings print.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive: Strategic Restructuring and Innovation Drive Buy Rating
- Colgate-Palmolive Reports Modest Q2 2025 Growth
- Colgate-Palmolive’s Earnings Call: Mixed Outlook with Strategic Moves
- Colgate-Palmolive: Hold Rating Amid Challenging Market Conditions and Positive Long-Term Outlook
- Colgate-Palmolive price target raised to $95 from $94 at Jefferies